The FDA just approved Lipfendra, a first-of-its-kind pill from Merck that slashes LDL cholesterol by up to 59% — previously only achievable with expensive injections. This oral PCSK9 inhibitor is a massive win for the 30+ million Americans on statins who still can't hit their cholesterol targets, offering a cheaper, easier alternative to the injectable biologics that have plagued patients for years.

"This could completely reshape how we treat high-risk...